Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients

Abstract

Previous reports suggest a protective role for anti-La autoantibody against the development of lupus nephritis. We studied the effect of anti-La on the prevalence of nephritis in a large cohort of lupus patients. In addition, we determined the association between anti-La and the presence of the various other lupus manifestations. We studied 1100 lupus patients enrolled in the Lupus Family Registry and Repository. Only one lupus patient per family was selected to exclude intrafamilial correlation. Since anti-La is present in patients who also have anti-Ro autoantibody, we compared anti-Ro positive lupus patients in the presence or absence of anti-La. Clinical data were obtained from medical records, interviews and participant questionnaires. Tests for autoantibodies against extractable nuclear antigens were performed using immunodiffussion assays. There is no difference in the age, sex or race between the anti-La positive and anti-La negative lupus patients. The presence of anti-La is associated with a significant reduced risk of lupus nephritis (proteinuria: 29.3% versus 46.3%, OR = 0.48, P = 0.023; cellular casts: 8.6% versus 20.6%, OR = 0.36, P = 0.038). In addition, lupus patients with anti-La have a reduced risk for seizures (0% versus 10.9%, P = 0.0096) and are more likely to have arthritis (79.3% versus 64.0%, OR = 2.16, P = 0.031). The presence of anti-nRNP autoantibody is significantly reduced in anti-La positive compared with anti-La negative lupus patients (10.3% versus 27.4%, OR = 0.31, P = 0.0075). In conclusion, anti-La autoantibody is associated with less severe lupus. Patients with anti-La have a lower risk of renal involvement and seizures compared with anti-La negative lupus patients. Lupus (2007) 16, 863—866.

Keywords

Lupus anti-La nephritis seizures

Get full access to this article

View all access options for this article.

References

Kaslow RA , Masi AT Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum 1978 ; 21: 473—479.

Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2002; 16: 847—858.

Lawrence RC , Helmick CG , Arnett FC et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41: 778—799.

Priori R. , Medda E. , Conti F. et al. Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. Lupus 2003; 12: 735—740.

Sanchez-Guerrero J. , Lew RA , Fossel AH , Schur PH Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. Arthritis Rheum 1996; 39: 1055—1061.

Reichlin M. Antibodies to cytoplasmic antigens. In Lahita R ed. Systemic lupus erythematosus, third edition, San Diego: Academic Press , 1999: 219—226.

Sawalha AH , Harley JB Antinuclear autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 2004; 16(5): 534—540.

Reichlin M. , Wolfson-Reichlin M. Correlations of anti-dsDNA and anti-ribosomal P autoantibodies with lupus nephritis. Clin Immunol 2003; 108: 69—72.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271—1277.

10.

Clark G. , Reichlin M. , Tomasi TB, Jr. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. J Immunol 1969; 102: 117—122.

11.

Reichlin M. , Mattioli M. Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. N Engl J Med 1972; 286: 908—911.

12.

Wasicek CA , Reichlin M. Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La . J Clin Invest 1982; 69: 835—843.

13.

Zhang W. , Reichlin M. Some autoantibodies to Ro/SS-A and La/SS-B are antiidiotypes to anti-double-stranded DNA. Arthritis Rheum 1996; 39(3): 522—531.